NCT01773460View on ClinicalTrials.gov

Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane

PHASE3TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Everolimus

Everolimus is given beyond progress (comparison with placebo)

DRUG

Everolimus-placebo

Everolimus-placebo

Trial Locations (1)

63069

Klinikum Offenbach, Offenbach

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

GBG Forschungs GmbH

OTHER